Competitor Analysis: Evaluating Merck & Co And Competitors In Pharmaceuticals Industry
In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for…
Investigating Apple’s Standing In Technology Hardware, Storage & Peripherals Industry Compared To Competitors
In today’s fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze…
Dogecoin Down More Than 10% Within 24 hours
Over the past 24 hours, Dogecoin's (CRYPTO: DOGE) price has fallen 10.51% to $0.12. This continues its negative trend over the past week where it has experienced a 14.0% loss, moving from $0.14 to its current price.
Intra-Cellular Therapies’ Highlights Successful Data From Second Depression Study
Intra-Cellular Therapies reports positive topline results for Study 502 on lumateperone 42 mg as adjunctive therapy for major depressive disorder. FDA application expected in H2 2024.
(WYNN) – Analyzing Wynn Resorts’s Short Interest
Wynn Resorts’s (NYSE:WYNN) short percent of float has fallen 3.1% since its last report. The company recently reported…
Peering Into CenterPoint Energy’s Recent Short Interest
CenterPoint Energy’s (NYSE:CNP) short percent of float has risen 5.53% since its last report. The company recently reported…
Looking Into Sun Communities’s Recent Short Interest
Sun Communities’s (NYSE:SUI) short percent of float has risen 3.37% since its last report. The company recently reported…
US Stocks Mixed; Retail Sales Increase 0.1% In May
U.S. stocks traded mixed this morning, with the Nasdaq Composite edging lower on Tuesday. Following the market opening…
Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical’s $1.3B Deal
Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024.
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…